Postoperative Hemorrhage: Clinical Trials

12 trials for Postoperative Hemorrhage, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 3 terminated, 2 recruiting, 2 unknown. 12 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 312Completed 5, Terminated 3, Recruiting 2, Unknown 2
Phase 22Completed 1, Recruiting 1

Follow Postoperative Hemorrhage: new trials by email Literature Review of Postoperative Hemorrhage trials Research Report on Postoperative Hemorrhage

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Topical Estrogen: Brief Intervention to Improve Postoperative Experience for Transgender Men Undergoing Hysterectomy
Use of topical estradiol, No intervention - Postoperative Bleeding, Gender Dysphoria
Phase 3RecruitingWomen and Infants Hospital of Rhode Island482025-05-012025-05-13
Effect of Early Administration of TXA in Adult Hip Fractures
Tranexamic acid - Postoperative Blood Loss
Phase 2 / Phase 3RecruitingAscension Health1702021-09-012021-09-16
Preoperative Hexakapron Reduces Bleeding in Bariatric Surgery
tranexamic acid, Placebo - Intra-Operative Injury - Other, Post Operative Hemorrhage
Phase 3TerminatedSheba Medical Center1522017-09-012023-04-19
HepciFer Study: Hepcidin Overexpression After Hepatectomy : Does Iron Supplementation Make Sense ?
IV iron, IV placebo - Anemia, Postoperative Blood Loss
Phase 3CompletedUniversity Hospital, Geneva502015-10-012017-05-05
Intravenous Tranexamic Acid Versus Pericervical Tourniquet To Decrease Blood Loss In Trans-Abdominal Myomectomy
Tranexamic Acid, Pericervical Tourniquet - Post Operative Hemorrhage
Phase 3UnknownAin Shams Maternity Hospital702015-08-012016-04-12
Non-inferiority Trial of Oral Tranexamic Acid vs. Intravenous Tranexamic Acid in Joint Replacement Surgery
Tranexamic Acid (Oral), Tranexamic Acid (Intravenous) - Osteoarthritis, Blood Loss, Surgical
Phase 3UnknownThe New England Baptist Hospital1182015-04-012016-03-22
Tranexamic Acid in Reverse Total Shoulder Arthroplasty
Tranexamic Acid, Placebo - Shoulder Joint Disease, Complications; Arthroplasty
Phase 2 / Phase 3CompletedCorewell Health East1162013-09-012017-06-19
Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery
Fibrinogen Concentrate (Human) (FCH), Placebo - Surgical Blood Loss, Postoperative Blood Loss
Phase 3CompletedCSL Behring1522012-01-012014-09-18
Effect of Aprotinin on Transfusion Requirements in Patients Undergoing Elective Spinal Fusion Surgery
Trasylol (Aprotinin, BAYA0128), Placebo - Blood Loss, Surgical, Postoperative Hemorrhage
Phase 3TerminatedBayer542006-02-272019-06-04
Efficacy and Safety of Aprotinin on Transfusion Requirements in Patients Undergoing Radical or Total Cystectomy
Trasylol (Aprotinin, BAYA0128), Placebo - Blood Loss, Surgical, Postoperative Hemorrhage
Phase 3TerminatedBayer572005-12-012014-12-17
Hetastarch and Bleeding Complications After Off-Pump Coronary Bypass Surgery
hetastarch - Postoperative Hemorrhage
Phase 3CompletedKaiser Permanente3302004-09-012006-05-22
Optimal Heparin Dosing Regimens for Cardiopulmonary Bypass
Heparin, HH or high heparin, heparin concentration HC - Postoperative Hemorrhage
Phase 3CompletedMayo Clinic2702001-06-012009-10-15

Narrower conditions

Blood Loss, Surgical (5)  ·  Hemorrhage (2)  ·  Anemia (1)  ·  Arthritis (1)  ·  Gender Dysphoria (1)  ·  Intraoperative Complications (1)  ·  Joint Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Obesity, Morbid (1)  ·  Osteoarthritis (1)  ·  Pathologic Processes (1)  ·  Postoperative Complications (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (12)  ·  Pathologic Processes (11)  ·  Postoperative Complications (11)  ·  Hemorrhage (10)  ·  Intraoperative Complications (4)  ·  Arthritis (1)  ·  Body Weight (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Joint Diseases (1)  ·  Mental Disorders (1)  ·  Musculoskeletal Diseases (1)  ·  Nutrition Disorders (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Obesity (1)

Interventions

Tranexamic Acid (5)  ·  Aprotinin (2)  ·  Antifibrinolytic Agents (1)  ·  Fibrinogen (1)  ·  Heparin (1)  ·  Hydroxyethyl Starch Derivatives (1)  ·  Saline Solution (1)  ·  ferric carboxymaltose (1)  ·  ferryl iron (1)

Sponsors

Bayer (2)  ·  Ain Shams Maternity Hospital (1)  ·  Ascension Health (1)  ·  CSL Behring (1)  ·  Corewell Health East (1)  ·  Kaiser Permanente (1)  ·  Mayo Clinic (1)  ·  Sheba Medical Center (1)  ·  The New England Baptist Hospital (1)  ·  University Hospital, Geneva (1)  ·  Women and Infants Hospital of Rhode Island (1)

Countries

United States (7)  ·  Germany (3)  ·  Canada (2)  ·  United Kingdom (2)  ·  Austria (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Egypt (1)  ·  Finland (1)  ·  France (1)  ·  Israel (1)  ·  Italy (1)  ·  Japan (1)

Top investigators

Ahmad M BahaaEldin, MD (1)  ·  Eduardo Schiffer, MD (1)  ·  Kenneth Bauer, MD (1)  ·  Kevin Baker, PhD (1)  ·  Marketa Hecht, MD (1)  ·  Michael J Wiater, M.D. (1)  ·  Niels Rahe-Meyer, MD, PhD (1)  ·  William Oliver, MD (1)

Results publications

PMID 19698859, PMID 22777369, PMID 24947034, PMID 27317703, PMID 30252728, PMID 30462259, PMID 35123055, PMID 36089115, PMID 37553914, PMID 37581673, PMID 38823625

NIH funding

2005 (2)